Concord Medical Services Holdings Ltd (CCM) SEC Filings & Earnings Calls
EquiReason read 8 Concord Medical Services Holdings Ltd SEC filings in the last 12 months. Latest: 6-K on 2026-09-22 — Concord Medical Services announces non-reliance on previously issued FY2024 and FY2025 financial statements due to SEC staff comments on deconsolidation of CHG; auditor resignation.
Source: SEC EDGAR filings · read by EquiReason
- Market cap
- 17.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
22 Sep 20266-KConcord Medical Services announces non-reliance on previously issued FY2024 and FY2025 financial statements due to SEC staff comments on deconsolidation of CHG; auditor resignation and appointment of new auditor; intends to restate.open
Risks flagged
Non-reliance on previously issued financial statements for FY2024 and FY2025; restatement required.
“Company concluded that previously issued audited consolidated financial statements for FY2024 and FY2025 should no longer be relied upon.”
Going concern uncertainty as noted by prior auditor.
“Shandong Haoxin's audit reports contained an explanatory paragraph regarding the Company's ability to continue as a going concern.”
Material weakness in internal controls over financial reporting.
“Material weakness related to lack of accounting staff and resources with appropriate knowledge of U.S. GAAP and SEC reporting.”
Auditor resignation and change adds uncertainty to financial reporting process.
“Shandong Haoxin resigned as independent registered public accounting firm on September 14, 2026.”
2 Jul 20266-KCFO Wei Jiang stepped down; Botao Shi appointed interim CFO effective June 30, 2026. No disagreement cited.open
Risks flagged
CFO transition may cause temporary uncertainty in financial reporting continuity.
“CFO resignation effective immediately; interim CFO appointed.”
18 May 20266-KConcord Healthcare board changes: Liang Chang resigned as executive director; Li Jiang elected employee director. Management reviewing subsidiary consolidation status.open
Risks flagged
Potential deconsolidation of subsidiary could affect financial statements.
“Management reviewing whether Concord Healthcare continues to qualify as consolidated subsidiary.”
13 May 20266-KConcord Healthcare completed issue of 2% convertible bonds due 2027, aggregate principal HK$68 million.open
Figures in the filing · each found in the filing text
| Convertible bond principal · Concord Healthcare · 2026-05-13 | $68M |
Risks flagged
Convertible bond adds leverage at subsidiary level; potential dilution if converted.
“2% convertible bonds due 2027, HK$68 million principal.”
13 May 20266-KConcord Healthcare board changes: Wei Jiang appointed executive director; Liang Chang resigned; Li Jiang elected employee director.open
Risks flagged
Board turnover at subsidiary may indicate governance instability.
“Multiple board changes at Concord Healthcare.”
29 Apr 202620-FAnnual results for FY2025: revenue increased 19.9% YoY to RMB460.5M, net loss narrowed 41.8% to RMB379.4M, but going concern risk persists with negative equity and operating cash flow.earningsopen
Figures in the filing · each found in the filing text
| Weighted Average Interest Rate on Short-term Borrowings · FY2025 | 5.5% | |
| Weighted Average Interest Rate on Long-term Borrowings · FY2025 | 5.7% |
Risks flagged
Going Concern Risk
“These conditions raised substantial doubt about our ability to continue as a going concern.” · word for word
Liquidity and Debt Repayment Risk
“As of December 31, 2025, we had RMB430.4 million (US$61.5 million) in short-term borrowings outstanding and RMB550.7 million (US$78.7 million) in the current portion of long-term bank and other borrowings.” · word for word
Regulatory and Compliance Risk
“We conduct our business in a heavily regulated industry. The operation of our cancer hospitals and cooperative centers is subject to laws and regulations issued by a number of government agencies at the national and local levels.” · word for word
Internal Control Weakness
“The material weakness as of December 31, 2025 was related to the lack of accounting staff and resources with appropriate knowledge of U.S. GAAP and SEC reporting and compliance requirements.” · word for word
Concentration Risk
“In 2023, 2024 and 2025, net revenues derived from our cancer hospitals and clinics located in Shanghai and Guangzhou accounted for 57.4%, 69.8% and 81.2%, respectively, of our total net revenues in the same periods.” · word for word
Concord Medical Services Holdings Ltd — questions
- What did Concord Medical Services Holdings Ltd file recently?
- 8 SEC filings in the last 12 months. Latest: 6-K on 2026-09-22 — Concord Medical Services announces non-reliance on previously issued FY2024 and FY2025 financial statements due to SEC staff comments on deconsolidation of CHG; auditor resignation and appointment of new auditor; intends to restate.
Every figure on this page comes from Concord Medical Services Holdings Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.